open access

Vol 57, No 4 (2006)
Original paper
Submitted: 2013-02-15
Published online: 2006-07-07
Get Citation

The impact of the extent and time of operation on the survival in patients with differentiated thyroid carcinoma (DTC)

Agnieszka Czarniecka, Michał Jarząb, Jolanta Krajewska, Aleksander Sacher, Stanisław Półtorak, Jan Włoch
Endokrynol Pol 2006;57(4):347-355.

open access

Vol 57, No 4 (2006)
Original Paper
Submitted: 2013-02-15
Published online: 2006-07-07

Abstract

Introduction: To analyze the impact of time and extent of operation on overall and disease-free survival in patients with differentiated thyroid carcinoma (DTC).
Material and methods: Retrospective analysis of 1235 DTC patients, a representative probe of patients diagnosed or treated between 1986 to 1998 was performed. 277 patients were staged T1M0 and 958 ones staged > T1M0. 10-year outcomes were analyzed by Kaplan-Meier survival curves and Cox proportional-hazard model.
Results: The T1M0 patients were characterized by the best overall and disease-free survival independently of the time and the extent of operation (98% and 96% respectively); in > T1M0 group the survival was better in patients who were treated by total thyroidectomy (94% and 68% respectively) than in patients treated by non-total thyroidectomy (78% and 47% respectively). In patients treated by completion of total thyroidectomy delayed more than 1 year post cancer diagnosis the incidence of carcinoma in postoperative pathological material was twice as high in comparison to the group in whom total thyroidectomy was performed within the first year of therapy (p = 0.000).
Conclusions: 1. In differentiated thyroid carcinoma the prognosis is related to the extent of operation only in patients staged more than T1M0.
2. A delay > 12 months in completion surgery in patients with differentiated thyroid cancer (tumors > 1 cm of diameter) significantly increases the risk of progression of multifocal disease in thyroid remnants.

Abstract

Introduction: To analyze the impact of time and extent of operation on overall and disease-free survival in patients with differentiated thyroid carcinoma (DTC).
Material and methods: Retrospective analysis of 1235 DTC patients, a representative probe of patients diagnosed or treated between 1986 to 1998 was performed. 277 patients were staged T1M0 and 958 ones staged > T1M0. 10-year outcomes were analyzed by Kaplan-Meier survival curves and Cox proportional-hazard model.
Results: The T1M0 patients were characterized by the best overall and disease-free survival independently of the time and the extent of operation (98% and 96% respectively); in > T1M0 group the survival was better in patients who were treated by total thyroidectomy (94% and 68% respectively) than in patients treated by non-total thyroidectomy (78% and 47% respectively). In patients treated by completion of total thyroidectomy delayed more than 1 year post cancer diagnosis the incidence of carcinoma in postoperative pathological material was twice as high in comparison to the group in whom total thyroidectomy was performed within the first year of therapy (p = 0.000).
Conclusions: 1. In differentiated thyroid carcinoma the prognosis is related to the extent of operation only in patients staged more than T1M0.
2. A delay > 12 months in completion surgery in patients with differentiated thyroid cancer (tumors > 1 cm of diameter) significantly increases the risk of progression of multifocal disease in thyroid remnants.
Get Citation

Keywords

differentiated thyroid carcinoma; extent and time of surgery; prognosis

About this article
Title

The impact of the extent and time of operation on the survival in patients with differentiated thyroid carcinoma (DTC)

Journal

Endokrynologia Polska

Issue

Vol 57, No 4 (2006)

Article type

Original paper

Pages

347-355

Published online

2006-07-07

Page views

497

Article views/downloads

1084

Bibliographic record

Endokrynol Pol 2006;57(4):347-355.

Keywords

differentiated thyroid carcinoma
extent and time of surgery
prognosis

Authors

Agnieszka Czarniecka
Michał Jarząb
Jolanta Krajewska
Aleksander Sacher
Stanisław Półtorak
Jan Włoch

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl